Bingjun Sun

6.2k total citations · 2 hit papers
115 papers, 5.3k citations indexed

About

Bingjun Sun is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Bingjun Sun has authored 115 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Biomaterials, 67 papers in Biomedical Engineering and 45 papers in Molecular Biology. Recurrent topics in Bingjun Sun's work include Nanoparticle-Based Drug Delivery (74 papers), Nanoplatforms for cancer theranostics (61 papers) and RNA Interference and Gene Delivery (21 papers). Bingjun Sun is often cited by papers focused on Nanoparticle-Based Drug Delivery (74 papers), Nanoplatforms for cancer theranostics (61 papers) and RNA Interference and Gene Delivery (21 papers). Bingjun Sun collaborates with scholars based in China, United States and Japan. Bingjun Sun's co-authors include Zhonggui He, Jin Sun, Cong Luo, Xuanbo Zhang, Shiyi Zuo, Haotian Zhang, Qiming Kan, Qin Chen, Shenwu Zhang and Yu Han and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Bingjun Sun

103 papers receiving 5.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy

2018 370 citations Bingjun Sun, Cong Luo et al. Nano Letters profile →
Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy

2022 216 citations Zhonggui He, Bingjun Sun et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Bingjun Sun	3.2k	2.6k	2.0k	878	873	115	5.3k
Minjie Sun	2.2k 0.7×	1.5k 0.6×	1.7k 0.9×	551 0.6×	855 1.0×	129	4.5k
Ming Wu	2.8k 0.9×	1.2k 0.4×	1.6k 0.8×	722 0.8×	1.3k 1.5×	103	4.9k
Qi Yin	5.0k 1.6×	4.2k 1.6×	3.2k 1.6×	719 0.8×	1.4k 1.6×	86	8.2k
Xiaopin Duan	3.1k 1.0×	1.5k 0.6×	1.3k 0.7×	874 1.0×	1.3k 1.5×	44	5.0k
Wenbing Dai	2.2k 0.7×	2.6k 1.0×	2.3k 1.2×	290 0.3×	535 0.6×	133	5.5k
Qin He	3.0k 0.9×	3.0k 1.2×	3.3k 1.7×	401 0.5×	804 0.9×	181	7.0k
Tao Sun	2.0k 0.6×	1.8k 0.7×	2.0k 1.0×	376 0.4×	729 0.8×	130	5.0k
Lei Xing	1.7k 0.5×	1.3k 0.5×	2.0k 1.0×	766 0.9×	886 1.0×	118	4.9k
Meng Yu	2.6k 0.8×	1.2k 0.5×	1.6k 0.8×	512 0.6×	1.6k 1.9×	100	5.0k
Xianyi Sha	1.9k 0.6×	2.7k 1.1×	2.1k 1.0×	294 0.3×	625 0.7×	98	5.3k

Countries citing papers authored by Bingjun Sun

Since Specialization

Citations

This map shows the geographic impact of Bingjun Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingjun Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingjun Sun more than expected).

Fields of papers citing papers by Bingjun Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingjun Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingjun Sun. The network helps show where Bingjun Sun may publish in the future.

Co-authorship network of co-authors of Bingjun Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Bingjun Sun. A scholar is included among the top collaborators of Bingjun Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingjun Sun. Bingjun Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Danping, Shanhui Xu, Yixin Sun, et al.. (2025). Phospholipid‐Like Prodrug Liposomes with High Drug‐carrier Affinity and High Tumor Selectivity: Strong Competitors of Paclitaxel Nanomedicines. Advanced Functional Materials. 36(1).

Wang, Shuo, Yaqi Li, Wenjing Wang, et al.. (2025). Engineering stable prodrug self-assemblies by introducing the bromination effect. Journal of Controlled Release. 382. 113699–113699. 2 indexed citations

Xing, Jing, Cui-Yun Liu, Yaqi Li, et al.. (2025). Dual advantages of SN38 prodrug nanoassemblies overcome defects of irinotecan and SN38: enhanced stability and activatability. Science China Chemistry. 68(11). 5960–5970. 1 indexed citations

Hao, Yanzhong, Yaqiao Li, Xin Li, et al.. (2025). Self-assembled doxorubicin prodrug riding on the albumin express train enable tumor targeting and bio-activation. Journal of Colloid and Interface Science. 684(Pt 1). 97–108. 6 indexed citations

Lei, Tiantian, et al.. (2025). GPX4 Inhibitor-Driven Doxorubicin Homodimeric Prodrug Nanoassemblies with Synergistic Chemotherapy-Ferroptosis for Triple-Negative Breast Cancer Therapy. ACS Applied Nano Materials. 8(49). 23400–23413.

Zhang, Bowen, Xin Wang, Yi Zheng, et al.. (2025). Emerging selenium-containing nano-systems for cancer therapy. Coordination Chemistry Reviews. 548. 217159–217159.

Li, Wenxiao, Haiyu Zhao, Jiayu Guo, et al.. (2025). Effects of modification modules-adjusted intermolecular forces on docetaxel prodrug Nanoassemblies: From assembly mechanisms to in vivo fate. Journal of Controlled Release. 384. 113894–113894.

Zhang, Baoyuan, Shengbo Yuan, Shufang Zheng, et al.. (2025). Glycyrrhetinic acid-albumin nanoparticles with bimodal pharmacological activities for time-dependent restoration of acute liver injury. Nano Today. 65. 102849–102849.

Wang, Danping, Shuo Wang, Yingjie Zhao, et al.. (2024). Exploring the optimal chain length of modification module in disulfide bond bridged paclitaxel prodrug nanoassemblies for breast tumor treatment. Journal of Controlled Release. 375. 47–59. 6 indexed citations

10.

Wang, Danping, Qing Wang, Shiyi Zuo, et al.. (2024). Reductants supplement boost the antitumor efficacy of nanomedicine. Chemical Engineering Journal. 498. 155076–155076.

11.

Guo, Jiayu, Xiaoxiao Zhang, Simeng Wang, et al.. (2024). Revealing the impact of modified modules flexibility on gemcitabine prodrug nanoassemblies for effective cancer therapy. Journal of Colloid and Interface Science. 677(Pt A). 941–952. 2 indexed citations

12.

Liu, Jinrui, Bowen Zhang, Shufang Zheng, et al.. (2024). Optimizing the stable doxorubicin prodrug nanocomplex for efficient and selective cancer therapy. Chemical Engineering Journal. 504. 158945–158945.

13.

Xu, Yalin, Zixuan Wang, Xiyan Wang, et al.. (2024). Dual role of triglyceride structures facilitates anti-tumor drug delivery: Both as a self-assembling module and a responsive module. Journal of Colloid and Interface Science. 678(Pt C). 24–34. 2 indexed citations

14.

Zhang, Yu, Danping Wang, Shiyi Zuo, et al.. (2023). Rational design of tumor-selective prodrug nanoassemblies: Greatly improving the in vivo fate and tolerability of high-toxic cabazitaxel. Chemical Engineering Journal. 458. 141510–141510. 13 indexed citations

15.

Li, Lingxiao, Tian Liu, Shiyi Zuo, et al.. (2023). Satellite‐Type Sulfur Atom Distribution in Trithiocarbonate Bond‐Bridged Dimeric Prodrug Nanoassemblies: Achieving Both Stability and Activatability. Advanced Materials. 36(4). e2310633–e2310633. 29 indexed citations

16.

Li, Guanting, Shuwen Fu, Xuanbo Zhang, et al.. (2023). Smart stimuli-responsive carrier-free nanoassembly of SN38 prodrug as efficient chemotherapeutic nanomedicine. SHILAP Revista de lepidopterología. 2(1). 20 indexed citations

17.

Wang, Yingli, Jiang Yu, Dan Li, et al.. (2021). Paclitaxel derivative-based liposomal nanoplatform for potentiated chemo-immunotherapy. Journal of Controlled Release. 341. 812–827. 43 indexed citations

18.

Wang, Yingli, Yingli Wang, Jiamei Wang, et al.. (2019). Redox dual-responsive paclitaxel-doxorubicin heterodimeric prodrug self-delivery nanoaggregates for more effective breast cancer synergistic combination chemotherapy. Nanomedicine Nanotechnology Biology and Medicine. 21. 102066–102066. 29 indexed citations

19.

Sun, Bingjun, Yao Chen, Yu Han, et al.. (2019). Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy. Acta Biomaterialia. 92. 219–228. 96 indexed citations

20.

Sun, Bingjun, Cong Luo, Yu Han, et al.. (2018). Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy. Nano Letters. 18(6). 3643–3650. 370 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact